Table 1

List of symbols

Symbol

Definition

Sample value used

Parameter range


CU

Unvaccinated female children

(state variable)

AU

Unvaccinated adult women

(state variable)

CV

Vaccinated female children

(state variable)

AV

Vaccinated adult women

(state variable)

IU

Uninfected adult women

(state variable)

IV

Infected adult women

(state variable)

M

Uninfected men

(state variable)

N

Infected men

(state variable)

πW

Rate of appearance of new females

50 per year

0–100

πM

Rate of appearance of new males

50 per year

0–100

ε

Vaccine immunogenicity in female children

98%

75–98%

<a onClick="popup('http://www.biomedcentral.com/1471-2458/8/114/mathml/M5','MathML',630,470);return false;" target="_blank" href="http://www.biomedcentral.com/1471-2458/8/114/mathml/M5">View MathML</a>

Vaccine immunogenicity in adult women

98%

75–98%

p

Proportion of female children vaccinated

77%

0–100%

<a onClick="popup('http://www.biomedcentral.com/1471-2458/8/114/mathml/M4','MathML',630,470);return false;" target="_blank" href="http://www.biomedcentral.com/1471-2458/8/114/mathml/M4">View MathML</a>

Proportion of adult women vaccinated

40%

0–100%

μC

Mortality rate of children

1/70 years -1

1/140–1/13

μ

Leaving rate of adults

1/10 years-1

1/12–1

α

Rate of progression of female children to sexually activity

<a onClick="popup('http://www.biomedcentral.com/1471-2458/8/114/mathml/M25','MathML',630,470);return false;" target="_blank" href="http://www.biomedcentral.com/1471-2458/8/114/mathml/M25">View MathML</a>

1/12–1

c

Attentuation constant

0.15 years-1

0–0.3

γ

Maximal possible rate of adult vaccination

0.1

0–0.2

<a onClick="popup('http://www.biomedcentral.com/1471-2458/8/114/mathml/M26','MathML',630,470);return false;" target="_blank" href="http://www.biomedcentral.com/1471-2458/8/114/mathml/M26">View MathML</a>

Rate at which unvaccinated adult women are vaccinated

<a onClick="popup('http://www.biomedcentral.com/1471-2458/8/114/mathml/M27','MathML',630,470);return false;" target="_blank" href="http://www.biomedcentral.com/1471-2458/8/114/mathml/M27">View MathML</a>

βN

Probability of infection of a woman by an infected man

0.00056

0–0.00112

βM

Probability of infection of a man by an infected woman

0.0003

0–0.0006

ψ

Vaccine efficacy

95%

85–95%


Sample parameters were chosen so that <a onClick="popup('http://www.biomedcentral.com/1471-2458/8/114/mathml/M28','MathML',630,470);return false;" target="_blank" href="http://www.biomedcentral.com/1471-2458/8/114/mathml/M28">View MathML</a> (ie the total time between vaccination and leaving was always 13 years), γc-1 = 16.67 (ie the optimum age of vaccination for a perfect vaccine with 100% coverage was 16 years 9 months), βN > βM (ie the transmission probability from men to women was higher than from women to men), the total prevalence without vaccination was 24% and so that the proportion of adult-only vaccination was equal to the proportion of childhood-only vaccination required to eradicate targeted types.

Llamazares and Smith? BMC Public Health 2008 8:114   doi:10.1186/1471-2458-8-114

Open Data